サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1779860

造影超音波の世界市場

Contrast Enhanced Ultrasound

出版日
ページ情報
英文 359 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
造影超音波の世界市場
出版日: 2025年07月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 359 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

造影超音波の世界市場は2030年までに27億米ドルに到達

2024年に21億米ドルと推定される造影超音波の世界市場は、2024年から2030年にかけてCAGR 4.2％で成長し、2030年には27億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである超音波装置は、CAGR 5.1％を記録し、分析期間終了時には16億米ドルに達すると予測されます。超音波造影剤セグメントの成長率は、分析期間でCAGR 3.0％と推定されます。

米国市場は5億7,070万米ドルと推定、中国はCAGR7.8％で成長予測

米国の造影超音波市場は、2024年に5億7,070万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.8%として、2030年までに5億5,270万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と3.2%と予測されています。欧州では、ドイツがCAGR 2.4%で成長すると予測されています。

世界の造影超音波市場動向と市場促進要因

造影超音波が医療画像診断で重要性を増しているのはなぜか？

造影超音波は、CTやMRIのような従来の画像診断法に代わる、より安全で費用対効果が高く、詳細な診断法を提供し、医療画像診断の分野を急速に変革しています。マイクロバブル造影剤を使用することで、この技術は血流、血管構造、組織灌流の可視化を強化し、様々な臨床応用における診断精度を大幅に向上させる。類似した組織密度を区別するのに苦労することが多い従来の超音波とは異なり、造影超音波はより高い感度でリアルタイムのイメージングを提供するため、腫瘍、炎症、虚血領域などの異常をより的確に検出することができます。

造影超音波の採用を促進する主な要因の1つは、その安全性プロファイルです。CTやMRI検査で使用される従来の造影剤にはヨウ素やガドリニウムが含まれており、特に腎機能障害のある患者にはアレルギー反応や腎毒性のリスクがあります。対照的に、マイクロバブルをベースとする超音波造影剤は生物学的に不活性で、体内から速やかに排出されるため、安全性に優れています。さらに、造影超音波検査は電離放射線を伴わないため、小児や妊娠中の患者にとって好ましい選択です。非侵襲的で放射線を使用しない画像診断ソリューションへの需要は高まっており、造影超音波は現代の診断ワークフローにおける貴重なツールとなっています。

技術の進歩は造影超音波をどのように強化しているか？

超音波イメージング技術の進歩により、造影超音波の機能と精度が大幅に向上し、さまざまな病態の検出と特徴付けがより効果的になりました。最も注目すべき技術革新のひとつは、リアルタイムの灌流画像の開発であり、これにより臨床医は微小血管の血流動態を評価し、組織や臓器の異常をより正確に特定できるようになりました。これは特に腫瘍学において有用であり、腫瘍血管の可視化を強化することで、良性病変と悪性病変を区別し、がんの早期発見と治療計画に役立てることができます。

もう一つの重要な進歩は、造影超音波解析における人工知能と機械学習の統合です。AI主導の画像解釈アルゴリズムは、灌流パターンの変化を自動的に検出して定量化することができ、オペレーターの依存度を減らし、診断の一貫性を向上させる。さらに、新世代の超音波装置は、より高い空間分解能、改良されたハーモニックイメージング、強化されたドップラー機能を備えており、造影超音波の血流と組織灌流を可視化する能力にさらに磨きをかけています。このような技術改良により、造影超音波は精密医療に不可欠なツールとなりつつあり、様々な病状に合わせた画像ソリューションを提供しています。

造影超音波の主な産業用途は？

造影超音波は、臨床医が疾患を診断・モニタリングする方法に革命をもたらし、複数の医療専門分野でますます利用されるようになっています。主な用途の1つは肝臓病学で、肝臓病変、肝硬変、肝灌流異常の評価に使用されています。造影超音波検査は、良性肝腫瘍と悪性肝腫瘍を区別できるため、特に慢性肝疾患の患者を対象とした肝がんスクリーニングにおいて好ましい画像診断法となっています。さらに、肝細胞がん患者の肝生検の誘導や治療効果のモニタリングにも重要な役割を果たしています。

心臓病学では、造影超音波検査は心筋灌流の評価、虚血性心疾患の検出、心機能の評価に広く用いられています。造影超音波検査は微小血管の血流を可視化することにより、心臓専門医が標準的な心エコー検査では見えないような微妙な灌流障害を検出するのに役立ちます。造影超音波は腎臓病学でも支持を集めており、腎臓疾患の診断、腎灌流の評価、血管異常の検出に役立っています。その他の新たな用途としては、乳がん、前立腺がん、膵臓がんの検出を助ける腫瘍学や、炎症状態や軟部組織の脈管形成を評価するための筋骨格系イメージングがあります。医療界が造影超音波の利点を認識し続けるにつれて、その使用は様々な診断や介入手技に広がっています。

造影超音波市場の成長を促進する要因は？

造影超音波市場の成長は、非侵襲的イメージング技術に対する需要の増加、超音波技術の進歩、詳細な血管評価を必要とする慢性疾患の有病率の増加など、いくつかの要因によってもたらされます。ヘルスケアプロバイダーがCTやMRIに代わる、より安全で費用対効果の高いものを求める中、造影超音波は、放射線が不要で診断精度が高いことから、好まれる画像診断法として台頭してきています。肝疾患、心血管障害、がんの罹患率の増加は、高度な画像ソリューションの必要性をさらに加速しており、造影超音波は疾患の検出と管理における重要なツールとして位置づけられています。

人工知能とリアルタイム画像解析の統合が造影超音波判読の精度と効率を高めていることも主要な促進要因です。また、携帯型超音波診断装置やポイントオブケア超音波診断装置の採用が増加していることも、救急医療、重症患者、外来患者などでの幅広い利用を可能にし、市場の成長を後押ししています。さらに、造影超音波検査に対する規制当局の承認や償還政策の拡大も、ヘルスケアプロバイダーによる採用拡大を後押ししています。リアルタイムの高解像度画像に対する需要が拡大し続ける中、造影超音波は現代の医療診断に欠かせない存在となり、幅広い臨床用途でより迅速、安全、高精度の画像ソリューションを提供します。

セグメント

製品タイプ（超音波装置、超音波造影剤）;CEUSタイプ（非標的CEUS、標的CEUS）;エンドユース（病院エンドユース、診療所エンドユース、外来診断センターエンドユース）

調査対象企業の例

  • Acusphere Inc.
  • Alpinion Medical Systems
  • BK Medical Holding Company Inc.
  • Bracco Diagnostic Inc.
  • Canon Medical Systems Corporation
  • Chison Medical Technology Co., Ltd.
  • ContextVision AB
  • Esaote S.p.A.
  • FUJIFILM VisualSonics Inc.
  • GE Healthcare
  • Hitachi Healthcare
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Leriva Pharma S.A.
  • nanoPET Pharma GmbH
  • Samsung Healthcare
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers
  • Trivitron Healthcare Pvt. Ltd.

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMをクエリする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30226

Global Contrast Enhanced Ultrasound Market to Reach US$2.7 Billion by 2030

The global market for Contrast Enhanced Ultrasound estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Ultrasound Equipment, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Ultrasound Contrast Agents segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$570.7 Million While China is Forecast to Grow at 7.8% CAGR

The Contrast Enhanced Ultrasound market in the U.S. is estimated at US$570.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$552.7 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Contrast-Enhanced Ultrasound Market - Trends, Innovations & Growth Drivers

Why Is Contrast-Enhanced Ultrasound Gaining Importance in Medical Imaging?

Contrast-enhanced ultrasound is rapidly transforming the field of medical imaging, offering a safer, cost-effective, and highly detailed diagnostic alternative to traditional imaging modalities such as CT and MRI. By using microbubble contrast agents, this technology enhances the visualization of blood flow, vascular structures, and tissue perfusion, significantly improving diagnostic accuracy in various clinical applications. Unlike conventional ultrasound, which often struggles to differentiate between similar tissue densities, contrast-enhanced ultrasound provides real-time imaging with higher sensitivity, allowing for better detection of abnormalities such as tumors, inflammation, and ischemic regions.

One of the major factors driving the adoption of contrast-enhanced ultrasound is its safety profile. Traditional contrast agents used in CT and MRI scans contain iodine and gadolinium, which pose risks of allergic reactions and nephrotoxicity, especially in patients with kidney dysfunction. In contrast, microbubble-based ultrasound contrast agents have an excellent safety record, as they are biologically inert and quickly eliminated from the body. Additionally, contrast-enhanced ultrasound does not involve ionizing radiation, making it a preferred choice for pediatric and pregnant patients. The demand for non-invasive, radiation-free imaging solutions is increasing, making contrast-enhanced ultrasound a valuable tool in modern diagnostic workflows.

How Are Technological Advancements Enhancing Contrast-Enhanced Ultrasound?

Advancements in ultrasound imaging technology have significantly improved the capabilities and accuracy of contrast-enhanced ultrasound, making it more effective in detecting and characterizing various pathologies. One of the most notable innovations is the development of real-time perfusion imaging, which allows clinicians to assess microvascular blood flow dynamics and identify abnormalities in tissues and organs with greater precision. This is particularly useful in oncology, where enhanced visualization of tumor vascularity can help differentiate between benign and malignant lesions, aiding in early cancer detection and treatment planning.

Another key advancement is the integration of artificial intelligence and machine learning in contrast-enhanced ultrasound analysis. AI-driven image interpretation algorithms can automatically detect and quantify changes in perfusion patterns, reducing operator dependency and improving diagnostic consistency. Additionally, new-generation ultrasound machines feature higher spatial resolution, improved harmonic imaging, and enhanced Doppler capabilities, further refining contrast-enhanced ultrasound’s ability to visualize blood flow and tissue perfusion. With these technological improvements, contrast-enhanced ultrasound is becoming an essential tool in precision medicine, offering tailored imaging solutions for various medical conditions.

What Are the Key Industry Applications of Contrast-Enhanced Ultrasound?

Contrast-enhanced ultrasound is being increasingly utilized across multiple medical specialties, revolutionizing the way clinicians diagnose and monitor diseases. One of the primary applications is in hepatology, where it is used to assess liver lesions, cirrhosis, and hepatic perfusion abnormalities. The ability of contrast-enhanced ultrasound to differentiate between benign and malignant liver tumors has made it a preferred imaging method in liver cancer screening, particularly for patients with chronic liver disease. Additionally, it plays a critical role in guiding liver biopsies and monitoring treatment response in hepatocellular carcinoma patients.

In cardiology, contrast-enhanced ultrasound is widely used for evaluating myocardial perfusion, detecting ischemic heart disease, and assessing cardiac function. By enhancing the visualization of microvascular blood flow, it helps cardiologists detect subtle perfusion defects that may not be visible on standard echocardiography. Contrast-enhanced ultrasound is also gaining traction in nephrology, where it assists in diagnosing kidney diseases, assessing renal perfusion, and detecting vascular abnormalities. Other emerging applications include oncology, where it aids in the detection of breast, prostate, and pancreatic cancers, as well as musculoskeletal imaging for evaluating inflammatory conditions and soft tissue vascularization. As the medical community continues to recognize the advantages of contrast-enhanced ultrasound, its use is expanding across various diagnostic and interventional procedures.

What Factors Are Driving Growth in the Contrast-Enhanced Ultrasound Market?

The growth in the contrast-enhanced ultrasound market is driven by several factors, including increasing demand for non-invasive imaging techniques, advancements in ultrasound technology, and the growing prevalence of chronic diseases requiring detailed vascular assessment. As healthcare providers seek safer and more cost-effective alternatives to CT and MRI, contrast-enhanced ultrasound is emerging as a preferred imaging modality due to its radiation-free nature and high diagnostic accuracy. The rising incidence of liver disease, cardiovascular disorders, and cancer has further accelerated the need for advanced imaging solutions, positioning contrast-enhanced ultrasound as a critical tool in disease detection and management.

Another key driver is the integration of artificial intelligence and real-time image analysis, which is enhancing the accuracy and efficiency of contrast-enhanced ultrasound interpretation. The increasing adoption of portable and point-of-care ultrasound systems is also fueling market growth, allowing for broader accessibility in emergency medicine, critical care, and outpatient settings. Additionally, regulatory approvals and expanded reimbursement policies for contrast-enhanced ultrasound procedures are encouraging greater adoption among healthcare providers. As the demand for real-time, high-resolution imaging continues to grow, contrast-enhanced ultrasound is set to become an indispensable part of modern medical diagnostics, providing faster, safer, and more precise imaging solutions across a wide range of clinical applications.

SCOPE OF STUDY:

The report analyzes the Contrast Enhanced Ultrasound market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Ultrasound Equipment, Ultrasound Contrast Agents); CEUS Type (Non-Targeted CEUS, Targeted CEUS); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Diagnostic Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Acusphere Inc.
  • Alpinion Medical Systems
  • BK Medical Holding Company Inc.
  • Bracco Diagnostic Inc.
  • Canon Medical Systems Corporation
  • Chison Medical Technology Co., Ltd.
  • ContextVision AB
  • Esaote S.p.A.
  • FUJIFILM VisualSonics Inc.
  • GE Healthcare
  • Hitachi Healthcare
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Leriva Pharma S.A.
  • nanoPET Pharma GmbH
  • Samsung Healthcare
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers
  • Trivitron Healthcare Pvt. Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Contrast Enhanced Ultrasound - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Liver, Kidney, and Cardiovascular Diseases Drives Clinical Adoption of CEUS
    • Radiation-Free Imaging Alternatives Strengthen the Business Case for Contrast-Enhanced Ultrasound Over CT and MRI
    • Increased Use of CEUS in Oncology Supports Demand for Real-Time, Non-Invasive Tumor Characterization
    • FDA and EMA Approvals for New Contrast Agents Expand Clinical Applications Across Regions
    • Advancements in Microbubble Contrast Agents Enhance Image Resolution and Diagnostic Accuracy
    • Growing Awareness Among Radiologists and Sonographers Boosts Utilization Rates in Hospitals and Imaging Centers
    • Demand for Bedside and Point-of-Care Diagnostics Propels CEUS Use in Emergency and Critical Care Settings
    • Pediatric and Pregnant Patient Populations Drive Need for Safer, Non-Ionizing Imaging Modalities
    • Healthcare Cost Optimization Goals Promote CEUS as a Lower-Cost Alternative to Cross-Sectional Imaging
    • Clinical Expansion Into Cardiac, Vascular, and GI Imaging Broadens the CEUS Use Case Portfolio
    • OEM Innovations in Ultrasound Systems With CEUS Capabilities Improve Workflow Integration
    • CEUS-Guided Biopsies and Interventional Procedures Enhance Clinical Outcomes and Expand Adoption
    • Increased Use in Chronic Disease Management and Monitoring Drives Repeat Imaging Demand
    • Supportive Reimbursement Structures in Europe and Select U.S. States Accelerate Institutional Adoption
    • Growing Preference for Portable and Handheld Ultrasound Devices Expands CEUS Accessibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Contrast Enhanced Ultrasound Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Contrast Enhanced Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ultrasound Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ultrasound Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ultrasound Contrast Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ultrasound Contrast Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Ultrasound Contrast Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Non-Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Non-Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Non-Targeted CEUS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Targeted CEUS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Targeted CEUS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Contrast Enhanced Ultrasound by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: India 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Contrast Enhanced Ultrasound by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Contrast Enhanced Ultrasound Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Contrast Enhanced Ultrasound by Product Type - Ultrasound Equipment and Ultrasound Contrast Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by Product Type - Percentage Breakdown of Value Sales for Ultrasound Equipment and Ultrasound Contrast Agents for the Years 2015, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Contrast Enhanced Ultrasound by CEUS Type - Non-Targeted CEUS and Targeted CEUS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by CEUS Type - Percentage Breakdown of Value Sales for Non-Targeted CEUS and Targeted CEUS for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Contrast Enhanced Ultrasound by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Contrast Enhanced Ultrasound by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Diagnostic Centers End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION